• ქართული
  • English
  • Jury says J&J must pay $8 billion in case over male breast growth linked to Risperdal

    Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.

    Market Quotes by TradingView